美股新聞 標題聯播 · 近 24 小時 336 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · JANX近 30 天 3 則 · 第 1 / 1 頁
- Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013
- Chipotle downgraded, Darden upgraded: Wall Street's top analyst calls
- JANX Shares Gain 19.1% in 3 Months: Here's What You Need to Know
- Janux Therapeutics (JANX) Is Up 7.1% After Reporting Narrower Net Losses And Improved Earnings Profile
- Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates
- Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
- Is Janux Therapeutics’ (JANX) Russell Index Exit Quietly Rewriting Its Investor Base and Story?
- VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone
- Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?
- Akari Therapeutics Highlights 1st ASCO Abstract Acceptance
- VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC
- Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know
- Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。